These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15818515)

  • 1. [Motor disturbances in psychiatric patients].
    Rüther E
    Psychiatr Prax; 2005 Apr; 32 Suppl 1():S3-6. PubMed ID: 15818515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Three-dimensional ultrasonic movement analysis of gait and hand-movements in schizophrenic patients].
    Putzhammer A; Perfahl M; Pfeiff L; Müller JL
    Psychiatr Prax; 2005 Apr; 32 Suppl 1():S38-42. PubMed ID: 15818519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extrapyramidal symptoms in unmedicated schizophrenia.
    McCreadie RG; Srinivasan TN; Padmavati R; Thara R
    J Psychiatr Res; 2005 May; 39(3):261-6. PubMed ID: 15725424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extrapyramidal syndromes and new antipsychotic drugs: findings in patients and non-human primate models.
    Casey DE
    Br J Psychiatry Suppl; 1996 May; (29):32-9. PubMed ID: 8733821
    [No Abstract]   [Full Text] [Related]  

  • 5. [Motor disturbances in psychosis].
    Putzhammer A; Hajak G
    Psychiatr Prax; 2005 Apr; 32 Suppl 1():S1-2. PubMed ID: 15818514
    [No Abstract]   [Full Text] [Related]  

  • 6. Motoric neurological soft signs and psychopathological symptoms in schizophrenic psychoses.
    Jahn T; Hubmann W; Karr M; Mohr F; Schlenker R; Heidenreich T; Cohen R; Schröder J
    Psychiatry Res; 2006 Jun; 142(2-3):191-9. PubMed ID: 16650902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency and differential diagnosis of depressive syndromes in schizophrenia.
    Martin RL; Cloninger CR; Guze SB; Clayton PJ
    J Clin Psychiatry; 1985 Nov; 46(11 Pt 2):9-13. PubMed ID: 2865255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Extrapyramidal side-effects: avoidance, diagnosis and treatment].
    Fleischhacker WW; Widschwendter C
    Psychiatr Prax; 2005 Apr; 32 Suppl 1():S25-30. PubMed ID: 15818517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of obsessive-compulsive disorder in schizophrenia and significance of motor symptoms.
    Krüger S; Bräunig P; Höffler J; Shugar G; Börner I; Langkrär J
    J Neuropsychiatry Clin Neurosci; 2000; 12(1):16-24. PubMed ID: 10678507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of subjective and objective quality of life in outpatients with schizophrenia.
    Yamauchi K; Aki H; Tomotake M; Iga J; Numata S; Motoki I; Izaki Y; Tayoshi S; Kinouchi S; Sumitani S; Tayoshi S; Takikawa Y; Kaneda Y; Taniguchi T; Ishimoto Y; Ueno S; Ohmori T
    Psychiatry Clin Neurosci; 2008 Aug; 62(4):404-11. PubMed ID: 18778437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Exacerbation of catatonic symptoms in neuroleptic therapy].
    Bräunig P; Krüger S; Höffler J
    Nervenarzt; 1995 May; 66(5):379-82. PubMed ID: 7609820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Four oral motor disorders: bruxism, dystonia, dyskinesia and drug-induced dystonic extrapyramidal reactions.
    Clark GT; Ram S
    Dent Clin North Am; 2007 Jan; 51(1):225-43, viii-ix. PubMed ID: 17185068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of subjective well-being in schizophrenic patients with gait parameters, expert-rated motor disturbances, and psychopathological status.
    Putzhammer A; Perfahl M; Pfeiff L; Hajak G
    Pharmacopsychiatry; 2005 May; 38(3):132-8. PubMed ID: 15902585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parallels between neuroleptic effects and lethargic encephalitis: the production of dyskinesias and cognitive disorders.
    Breggin PR
    Brain Cogn; 1993 Sep; 23(1):8-27. PubMed ID: 8105824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A discriminant validity study of negative symptoms with a special focus on depression and antipsychotic medication.
    Lewine RR
    Am J Psychiatry; 1990 Nov; 147(11):1463-6. PubMed ID: 1977328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basal ganglia T2 relaxation times in schizophrenia: a quantitative magnetic resonance imaging study in relation to tardive dyskinesia.
    Buckley P; O'Callaghan E; Mulvany F; Larkin C; Stack JP; Redmond O; Ennis JT; Thompson P; Waddington JL
    Psychiatry Res; 1995 Aug; 61(2):95-102. PubMed ID: 7480392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychological factors in susceptibility to drug-induced extrapyramidal symptoms.
    Levinson P; Malen R; Hogben G; Smith H
    Am J Psychiatry; 1978 Nov; 135(11):1375-6. PubMed ID: 707640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing negative symptoms and extrapyramidal symptoms in schizophrenia: workshop report.
    Kane JM; Dauphinais D; Barnes TR; Adler LA; Rifkin A
    Psychopharmacol Bull; 1993; 29(1):45-9. PubMed ID: 8104351
    [No Abstract]   [Full Text] [Related]  

  • 19. Specificity of the Calgary Depression Scale for schizophrenics.
    Addington D; Addington J; Maticka-Tyndale E
    Schizophr Res; 1994 Feb; 11(3):239-44. PubMed ID: 8193062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Affective flattening, schizophrenia, and akinesia.
    Rifkin A
    Am J Psychiatry; 1980 Jan; 137(1):129. PubMed ID: 7352554
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.